InsidersTradesSigma
Follow the 파미셀 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 파미셀 has recorded 49 public disclosures. Market capitalisation: €615.6bn. The latest transaction was reported on 10 July 2026 (Purchase). Among the most active insiders: 김현수. The full history is free.
49
Insider Decl.
n/a
Thresholds
n/a
34 ops.
Buy Volume
n/a
1 ops.
Sell Volume
17Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,046 of 29,063 companies
59.2
score / 100
Value56
Quality63
FCF yld5.1%
Earn yld6.1%
EV/EBITDA17.7x
ROE-29%
Gross mgn44%
Net mgn35%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 July 2026
Declarations49 total
25 of 49 declarations
About 파미셀
파미셀 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of innovative pharmaceutical products.